The role of positron emission tomography scan with 18F-fluorodeoxyglucose (FDG-PET) as the chief predictor of autologous stem cell transplantation in aggressive B-cell non-Hodgkin lymphoma.

被引：0
|
作者：
Caroli, P. [1 ]
Fantini, L. [1 ]
Ambrosini, V. [1 ]
Lopci, E. [1 ]
Musto, A. [1 ]
Maffione, A. [1 ]
Golemi, A. [1 ]
Santi, I. [1 ]
Fuccio, C. [1 ]
Tsamita, C. [1 ]
Derenzini, E. [1 ]
Zinzani, P. [1 ]
Fanti, S. [1 ]
机构：
[1] Azienda Osped Univ Bologna, S Orsola Malpighi Univ Hosp, Bologna, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2009年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S335 / S336
页数：2
相关论文
共 50 条
  • [31] Positron emission tomography using F-18 fluorodeoxyglucose pre- and post-autologous stem cell transplant in non-Hodgkin's lymphoma
    P B Johnston
    G A Wiseman
    I N M Micallef
    Bone Marrow Transplantation, 2008, 41 : 919 - 925
  • [32] Prognostic value of 18F-fluorodeoxyglucose positron emission tomography using Deauville criteria in diffuse large B cell lymphoma treated with autologous hematopoietic stem cell transplantation
    Ying, Zhitao
    Mi, Lan
    Zhou, Nina
    Wang, Xuejuan
    Yang, Zhi
    Song, Yuqin
    Wang, Xiaopei
    Zheng, Wen
    Lin, Ningjing
    Tu, Meifeng
    Xie, Yan
    Ping, Lingyan
    Zhang, Chen
    Liu, Weiping
    Deng, Lijuan
    Zhu, Jun
    CHINESE JOURNAL OF CANCER RESEARCH, 2019, 31 (01) : 162 - 170
  • [33] FDG-PET Response-adapted Therapy Is 18F-Fluorodeoxyglucose Positron Emission Tomography a Safe Predictor for a Change of Therapy?
    Hutchings, Martin
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 28 (01) : 87 - +
  • [34] Autologous stem cell transplantation in aggressive non-Hodgkin's lymphoma
    Gisselbrecht, C
    ADVANCES IN HEMATOPOIETIC STEM CELL TRANSPLANTATION AND MOLECULAR THERAPY, 1998, 144 : 15 - 26
  • [35] Autologous stem cell transplantation in aggressive non-Hodgkin's lymphoma
    Gisselbrecht, C
    HEMATOLOGY AND CELL THERAPY, 1996, 38 (04) : 297 - 304
  • [36] MANAGEMENT OF PRIMARY TUMOURS OF THE THYMUS AND USEFULNESS OF 18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY (FDG-PET)
    Moraitis, Sotirios D.
    Gkiozos, Ioannis
    Kanakakis, Konstantinos
    Moraitis, Dimitrios S.
    Syrigos, Konstantinos N.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S944 - S945
  • [37] Prognostic value of 18F-fluorodeoxyglucose positron emission tomography using Deauville criteria in diffuse large B cell lymphoma treated with autologous hematopoietic stem cell transplantation
    Zhitao Ying
    Lan Mi
    Nina Zhou
    Xuejuan Wang
    Zhi Yang
    Yuqin Song
    Xiaopei Wang
    Wen Zheng
    Ningjing Lin
    Meifeng Tu
    Yan Xie
    Lingyan Ping
    Chen Zhang
    Weiping Liu
    Lijuan Deng
    Jun Zhu
    Chinese Journal of Cancer Research, 2019, 31 (01) : 162 - 170
  • [38] Predictive value of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) prior to high dose chemotherapy and autologous stem cell transplant in patients with Hodgkin's lymphoma: Results of 93 patients
    Abouzied, Mohei Eldin
    Al-Sugair, Abdelaziz
    Al Kadhi, Yusuf
    Dingle, Marybeth
    Abdelsalam, Mahmoud
    Soudy, Hussein
    Darwish, Alaa
    Eltigani, Amin
    Maghfoor, Irfan
    Akhtar, Saad
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [39] 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) prior to high-dose chemotherapy and autologous stem cell transplant predicts outcome after ASCT in patients with diffuse large cell lymphoma and Hodgkin's lymphoma. Results in 110 patients
    Akhtar, S.
    Al-Sugair, A.
    Abuzaid, M.
    Al Kadhi, Y.
    Dingle, M.
    Abdelsalam, M.
    Soudy, H.
    Darwish, A.
    Eltigani, A.
    Nabil, M.
    Maghfoor, I.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S247 - S247
  • [40] Positron emission tomography/computed tomography in the management of Hodgkin and B-cell non-Hodgkin lymphoma: An update
    Juweid, Malik E.
    Mueller, Marguerite
    Alhouri, Abdullah
    A-Risheq, M. Ziad
    Mottaghy, Felix M.
    CANCER, 2021, 127 (20) : 3727 - 3741
12345